1. Home
  2. MLP vs TLSI Comparison

MLP vs TLSI Comparison

Compare MLP & TLSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

MLP

Maui Land & Pineapple Company Inc.

HOLD

Current Price

$15.17

Market Cap

307.8M

Sector

Finance

ML Signal

HOLD

Logo TriSalus Life Sciences Inc.

TLSI

TriSalus Life Sciences Inc.

HOLD

Current Price

$4.13

Market Cap

270.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MLP
TLSI
Founded
1909
2010
Country
United States
United States
Employees
20
N/A
Industry
Real Estate
Medical Specialities
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
307.8M
270.2M
IPO Year
2010
2020

Fundamental Metrics

Financial Performance
Metric
MLP
TLSI
Price
$15.17
$4.13
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
★ $10.40
AVG Volume (30 Days)
10.7K
★ 294.1K
Earning Date
11-13-2026
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
N/A
★ N/A
Revenue
$19,457,000.00
★ $45,151,000.00
Revenue This Year
N/A
$17.65
Revenue Next Year
N/A
$40.27
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 68.24
53.41
52 Week Low
$13.84
$2.20
52 Week High
$19.92
$7.95

Technical Indicators

Market Signals
Indicator
MLP
TLSI
Relative Strength Index (RSI) 32.12 33.83
Support Level $15.14 $3.64
Resistance Level $16.45 $4.47
Average True Range (ATR) 0.51 0.35
MACD -0.07 -0.05
Stochastic Oscillator 44.71 1.15

Price Performance

Historical Comparison
MLP
TLSI

About MLP Maui Land & Pineapple Company Inc.

Maui Land & Pineapple Co Inc is a landholding and operating parent company that owns land and commercial property on the island of Maui, Hawaii. The Company puts its assets into productive use by planning, managing, developing, and selling residential, resort, commercial, agricultural, and industrial real estate. Its segments include land development and sales, which cover land planning, entitlement, development, construction, and sales of land assets; leasing, which generates revenue from real property leasing, license fees and royalties, and includes maintenance of real estate assets, conservation activities, and management of water systems in West and Upcountry Maui; and resort amenities, which include a membership program offering benefits within the Kapalua Resort.

About TLSI TriSalus Life Sciences Inc.

TriSalus Life Sciences Inc is an oncology-focused medical technology business integrating its delivery technology with standard-of-care therapies and its investigational immunotherapeutic, nelitolimod, a class C Toll-like receptor 9 (TRL9) agonist, for patients with solid tumors. The company developed Pressure-Enabled Drug Delivery (PEDD) to overcome high intratumoral pressure and off-target delivery. Its 510(k) cleared device, the TriNav Infusion System using PEDD technology, is used for interventional radiology procedures including transarterial radioembolization (TARE) and transarterial chemoembolization (TACE) in patients with primary liver cancer or liver metastases. It has one reportable segment and generates revenue from sales of PEDD infusion systems, principally related to TriNav.

Share on Social Networks: